Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
34 /100
MEDIUM RISK
Score updated Aug 28, 2026

WHWK — Whitehawk Therapeutics, Inc. Dilution Risk Tracker

Track WHWK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WHWK — Get alerts when the score changes →

As of August 28, 2026, Whitehawk Therapeutics, Inc. (WHWK) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. Whitehawk Therapeutics, Inc. has a market capitalization of $233.42M, 57.01M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include 317.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
10
📊 Float Risk
70
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for WHWK.
🔔 Track WHWK — Get forecast alerts →

Market Data

Market Cap$233.42M
Shares Outstanding57.01M
Float18.15M
Cash$189.98M
DebtN/A
Short InterestN/A

Institutional Holdings

10 institutional holders · 27.83M shares
#1 QVT Financial LP 4.62M shares
#2 Orbimed Advisors LLC. 4.17M shares
#3 Suvretta Capital Management, LLC 3.70M shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.43M
Days to Cover10.3
% of Float24.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31
xbrl XBRL CONVERTIBLE 2022-12-31
4 INSIDER TRANSACTION 2026-04-08
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-04-03
Full SEC filing analysis available with free account

Recent News

No recent news

Factual WHWK Dilution Snapshot

Whitehawk Therapeutics, Inc. (WHWK) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track WHWK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking WHWK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for WHWK
WHWK FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.